Emerging treatment options in the management of non-small cell lung cancer. - Wikidata - awgldk - TriplyDB

Emerging treatment options in the management of non-small cell lung cancer.

Emerging treatment options in the management of non-small cell lung cancer.

http://www.wikidata.org/entity/Q37645201

about

Computed tomography-guided implantation of 125I seeds brachytherapy for recurrent multiple pulmonary oligometastases: initial experience and results.

P2860

Q33704932-7B2A6DEF-2F96-4CEC-8BC4-8179D0965640

P2860

Emerging treatment options in the management of non-small cell lung cancer.

http://www.wikidata.org/entity/Q37645201

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 08 June 2011

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Emerging treatment options in the management of non-small cell lung cancer.

@en

Emerging treatment options in the management of non-small cell lung cancer.

@nl

type

label

Emerging treatment options in the management of non-small cell lung cancer.

@en

Emerging treatment options in the management of non-small cell lung cancer.

@nl

prefLabel

Emerging treatment options in the management of non-small cell lung cancer.

@en

Emerging treatment options in the management of non-small cell lung cancer.

@nl

P1433

Q37645201-9A387DDF-BD34-4360-9906-F6C47ECD75BB

P1476

Q37645201-86EB24F0-D5E5-43FB-B92E-AF2A9F05A706

P2093

Q37645201-25663936-AC3F-4679-9362-4A1C5B096836

Q37645201-44ACBDE8-AC76-4B7D-BD8A-FB70342E4520

Q37645201-675C4280-4A7F-4A06-97E7-F14759800458

Q37645201-A6654E5A-117F-49A9-AB1B-7C7ED24B9344

Q37645201-AFA13805-CC28-4B47-9AE1-F549A908F92C

Q37645201-CE6B5561-3BC8-40C9-A9FB-F9206B534CB7

Q37645201-E1F2D25B-D0BD-405B-93B6-CBF2FDB9A5CD

P2860

Q37645201-04CB899B-0E5E-4C1C-A2B2-874DF2F5AA16

Q37645201-0633EC0F-DAE1-44C6-BB20-5C17ACEE0972

Q37645201-06F9D93E-07F4-49CD-B845-CD9A172DE998

Q37645201-09502168-BEA3-4EE7-B52C-543903F1FABD

Q37645201-0F2D0730-69F0-480D-8D05-EF4BAA803332

Q37645201-0F8011C6-4EE6-4C47-A299-87ED5E3622B0

Q37645201-1092C0B6-45E0-4E20-B814-0831E5726A51

Q37645201-111393CF-852A-4129-BE15-9DB2917E5FCA

Q37645201-16301385-6CC2-4E47-829B-ADA713223E42

Q37645201-16ED8958-EF51-4A6A-95A9-1BFBFA838319

P304

Q37645201-4DC007C6-3F6F-4070-8DA6-429A4B8D80F6

P31

Q37645201-AB9FCFEE-535B-401F-9413-97417D0C3408

P356

Q37645201-5AF839F5-E455-4B1C-80C6-C3572DC698D5

P478

Q37645201-13D4CF33-C492-44EC-AED3-98214C4DF553

P50

Q37645201-4748477C-0459-4AED-8DE5-7033A7150F15

Q37645201-6AEFD036-EC2C-47B6-833F-77C97E5277EB

P577

Q37645201-1D93DE89-CFEF-4A56-9B2E-BFEADD441EFB

P698

Q37645201-F8D2C07A-0B65-4066-AD0C-A89C541FD8FA

P932

Q37645201-94091A0A-EC2E-4852-A4CB-96139C92015D

P356

P1433

Lung Cancer: Targets and Therapy

P1476

Emerging treatment options in the management of non-small cell lung cancer

@en

P2093

Alberto Oliaro

http://www.w3.org/2001/XMLSchema#string

Andrea Riccardo Filippi

http://www.w3.org/2001/XMLSchema#string

Enrico Ruffini

http://www.w3.org/2001/XMLSchema#string

Maria Carla Cassinis

http://www.w3.org/2001/XMLSchema#string

Paolo Olivo Lausi

http://www.w3.org/2001/XMLSchema#string

Pier Luigi Filosso

http://www.w3.org/2001/XMLSchema#string

Umberto Ricardi

http://www.w3.org/2001/XMLSchema#string

P2860

Tumor BRCA1, RRM1 and RRM2 mRNA expression levels and clinical response to first-line gemcitabine plus docetaxel in non-small-cell lung cancer patients

Abraxas and RAP80 form a BRCA1 protein complex required for the DNA damage response

RAP80 targets BRCA1 to specific ubiquitin structures at DNA damage sites

Ubiquitin-binding protein RAP80 mediates BRCA1-dependent DNA damage response

Impact of epidermal growth factor receptor and KRAS mutations on clinical outcomes in previously untreated non-small cell lung cancer patients: results of an online tumor registry of clinical trials

Smoking and carcinoma of the lung; preliminary report

The in vitro effect of gefitinib ('Iressa') alone and in combination with cytotoxic chemotherapy on human solid tumours

Novel mutant-selective EGFR kinase inhibitors against EGFR T790M

Inhibition of poly(ADP-ribose) polymerase in tumors from BRCA mutation carriers.

Targeting the DNA repair defect in BRCA mutant cells as a therapeutic strategy

P304

11-28

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2147/LCTT.S8618

http://www.w3.org/2001/XMLSchema#string

P478

2

http://www.w3.org/2001/XMLSchema#string

P50

P577

2011-06-08T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28210115

http://www.w3.org/2001/XMLSchema#string

P932

5312476

http://www.w3.org/2001/XMLSchema#string